Global /South Korea /Healthcare /Drug Manufacturers - General /123330

Genic Co., Ltd.

123330

• KRX: 123330 • Delayed

29,450KRW 4.1%

19.30 USD

As of 13 June 2026, Genic Co., Ltd. has a market cap of $151.52M USD, ranking #22815 globally and #984 in South Korea. It ranks #2047 in the Healthcare sector, and #737 in the Drug Manufacturers - General industry.

Global Rank

22815

Country Rank

984

Sector Rank

2047

Industry Rank

737

Key Stats

Market Cap

$151.52MUSD

230.44B KRW

Enterprise Value

$144.08MUSD

219.9B KRW

Revenue (TTM)

$51.42MUSD

78.2B KRW

EBITDA (TTM)

$11.1MUSD

16.94B KRW

Net Income (TTM)

$12.42MUSD

18.89B KRW

EBITDA Margin

22%

Profit Margin

24%

PE Ratio

12.2

PS Ratio

2.9

PB Ratio

5.6

EV/EBITDA

13.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Heo Nam open_in_new

Employees

324

Founded

2001

Website

genic21.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
4.1%	-6%	-13%	48%	43%	71%	22%	432%	319%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	123330 (주)제닉 ISIN: KR7123330003 Shares Out.: Shares Outstanding: 7.825M¹ Shares Float: 4.638M² TV: TradingView: KRX: 123330 SA: Stock Analysis: KRX: 123330 YF: Yahoo Finance: 123330.KS GF: Google Finance: KRX: 123330 BA: Barron's: 123330 MS: Morningstar: XKRX: 123330	29,450 KRW	TV: TradingView: KRX: 123330 SA: Stock Analysis: KRX: 123330 YF: Yahoo Finance: 123330.KS GF: Google Finance: KRX: 123330 BA: Barron's: 123330 MS: Morningstar: XKRX: 123330

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Genic Co., Ltd.

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 6K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 4K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 3K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 3K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 3K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 3K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 503K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 361K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 238K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 212K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 191K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 181K%	20.5	Switzerland

chevron_leftBack